Abiopharma

HARVARD BIOSCIENCE INC (HBIO)

Symbol	HBIO
Name	HARVARD BIOSCIENCE INC
Sector	INDUSTRIALS
Region	North America
Industry	Laboratory Analytical Instruments
Address	84 OCTOBER HILL RD, HOLLISTON, MA 01746
Telephone	5088938999
Fax	—
Email	—
Website	https://www.harvardbioscience.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001123494
Description	Harvard Bioscience Inc is a US-based developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America and Europe, it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS. The majority of its revenue comes from the United States. Additional info from NASDAQ: Harvard Bioscience Inc is a US-based developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America and Europe, it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS. The majority of its revenue comes from the United States.

2026-05-14 14:09

New Form SCHEDULE 13G/A - HARVARD BIOSCIENCE INC Filed: 2026-05-14 AccNo: 0001019432-26-000010 Size: 6 KB

2026-05-12 11:30

(19% Negative) HARVARD BIOSCIENCE INC (HBIO) Files Form 8-K

2026-05-12 11:30

(99% Positive) HARVARD BIOSCIENCE INC (HBIO) Reports Q2 2026 Financial Results

2026-05-12 11:30

Harvard Bioscience Announces First Quarter 2026 Financial Results

2026-05-07 11:30

Harvard Bioscience to Participate in Upcoming Investor Conferences

2026-04-28 11:30

Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET

2026-04-21 17:58

New Form DEFA14A - HARVARD BIOSCIENCE INC Filed: 2026-04-21 AccNo: 0001171843-26-002623 Size: 2 MB

2026-04-21 17:57

New Form DEF 14A - HARVARD BIOSCIENCE INC Filed: 2026-04-21 AccNo: 0001171843-26-002617 Size: 2 MB

2026-04-01 13:57

Frost Mark T 🟢 acquired 30.0K shares of HARVARD BIOSCIENCE INC (HBIO) Transaction Date: Mar 20, 2026 | Filing ID: 002156

2026-04-01 13:44

Frost Mark T 🟢 acquired 5.0K shares of HARVARD BIOSCIENCE INC (HBIO) at $5.00 Transaction Date: Mar 16, 2026 | Filing ID: 002155